Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Migoprotafib (GDC-1971) | 2377352-49-1 | 98.8% | 454.53 g·mol⁻1 | C25H26N8O | 5 MG
Supplier: Medchemexpress LLC HY1449035MG
Migoprotafib (GDC-1971) is an orally bioavailable, allosteric inhibitor of the protein tyrosine phosphatase SHP2 that inhibits the MAPK/ERK signaling pathway and has demonstrated antitumor activity in preclinical models. Supplied as a high-purity research reagent for laboratory studies.
- Allosteric SHP2 inhibition with demonstrated cellular activity.
- Inhibits MAPK/ERK signaling relevant to tumor growth.
- Orally bioavailable in in vivo studies, suitable for pharmacology research.
- High purity suitable for research applications (98.8%).
- Available in small-mass quantities for compound screening and dosing studies.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?